Selected Start-Ups (05/2008)
In Vivo briefly describes these recently founded companies: Arch Therapeutics, Astute Medical, Cavadis, Constellation Pharmaceuticals, Curetis, and Traycer Diagnostic.
You may also be interested in...
While an EU-level project is underway to address delays to drug trials that are conducted in combination with IVD performance studies, Denmark has streamlined its processes to address the issue at the national level.
Twelve new drugs are now being reviewed for potential EU marketing approval, including Servier’s vorasidenib for IDH-mutant diffuse glioma, which the company says could become the first targeted therapy for the malignant and incurable brain tumor.
The TGA has taken a series of actions to address supply chain issues, including on the regulatory front, but it says more remains to be done and is asking stakeholders for suggestions in a new online survey.